Systemic Diseases Flashcards

1
Q

Autoimmune disease which organs and cells undergo damage initially mediated by tissue binding autoAbs and immune complexes

A

SLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

SLE most common in

A

women of childbearing years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

SLE arthritis

A

migratory arthralgia, early morning stiff, tenosyno, small joint syno

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

SLE Rashes

A

Rash from exposure to UV light that is butterfly (raised/painful/itchy and on cheeks), subacute cutaneous lupus erythematous (migratory, annular), or discoid lupid lesions (hyperkeratosis, follicular plugging –> alopecia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

renal involvement in SLE

A

proliferative glomerulonephritis (tells a lot about prognosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

CV involvement in SLE

A

pericarditis, hypercoaguability associated with antiphospholipid antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pulm involvement in SLE

A

pleurisy or pleural effusion, increased risk of TE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Neuro involvement in SLE

A

fatigue, headache, poor concentration, hallucinations, chorea, psychosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Heme features of SLE

A

variety or neutro/lympho/thrombo/cytopenias and anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GI feature of SLE

A

mouth ulcers, mesenteric vasculitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

SLE treatment

A

NO CURE; educate patients, reduce inflammation, suppress immune system (glucocorticoids and immunosupressive agents)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Protective measures for SLE patients

A

suncreen, warm clothing, low dose aspirin, non-live immunizations, psychological support

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

main anti-inflamm agent for SLE and its toxicities

A

glucocorticoids - obesity, DM, atherosclerosis, osteoporosis, AVN, cataracts, infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

medication for SLE associated with fatigue, mild arthritis and mucocutaneous manifestations

A

antimalarial medications (safe for preggo but retinal toxicity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

if glucocorticoids aren’t effective then can use these two drugs in SLE

A

azthioprine (side effects: infections, heme malig) and MTX (side effects: infection, liver abnormalities, alopecia, pneumonitis, toxic for pregs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

internal organ involvement in SLE is treated with

A

mycophenolate mofetil (MMF) - inhibitor of purine synthesis of lymphocytes (good for nephritis tx)

17
Q

cyclophosphamide is used to treat SLE with these signs and has these toxicities

A

SLE with neuro, nephritis, vasculitis, internal organ damge –> reserved for most SEVERE diseases because pancytopenia, alopecia, mucositis, hemorrhagic cystitis (acute) and transitional cell CA, heme maligancy, sterility, premature menopause, infections (chronic)

18
Q

systemic sclerosis is

A
disorder of connective tissue affecting skin, organs, vasculature with sclerodactyly and Raynaud's 
40s and 50s
Females
LCSS (CREST)
DCSS
19
Q

components of SSc

A

fibrosis with overproduction of collagen and other connective tissue matrix proteins, vascular injury and obliteration, immune system activation

20
Q

Skin of SSc

A

non-pitting edema of fingers, shiny, taut, erythema and tortuous dilatation of capillary loops in nail fold bed, thin lips
restricted to sites distal to elbow/knee LCSS
restricted to sites proximal to elbow/knee DCSS

21
Q

GI involvement of SSc

A

smooth muscle atrophy and fibrosis in the lower 2/3 of the esophagus lead to reflux with erosive esophagitis –> dysphagia and odynophagia, stomach - early satiety/outlet obstruction, GI bleeding, bacterial overgrowth, pseudo obstruction

22
Q

Pulm involvement of SSc

A

major cause of morbidity and mortality; Pulm HTN (LCSS > DCSS), progressive dyspnea, RHF, angina

23
Q

Renal involvement of SSc

A

hypertensive renal crisis, malignant HTN and renal failure (DCSS > LCSS)

24
Q

Labs of scleroderma

A
ESR+
Raise level of IgG
ANA+ in 70%
30% of DCSS have Ab to topoisomerase 1 Scl-70 
60% of LCSS have anticentromere Ab
25
Q

Tx of scleroderma

A

ameliorate effects of diseases on target organs, avoid cold, Ca antags, angiotensin II blockers, epoprostenol for digital ischemia, antibiotics higher dose/longer course for infection, PPI for reflux, ACE-I for HTN, endothelin 1 antag for pulm HTN

26
Q

Sjogren’s syndrome is

A

autoimmune disorder of unknown cause characterized by lymphocytic infiltration of salivary and lachrymal glands –> leading to glandular fibrosis and exocrine failure
females

27
Q

Eye symptoms in Sjogren’s

A

keratoconjunctivitis sicca (lack of lubricating tears), conjunctivitis, blepharitis

28
Q

Oral involvement in Sjogren’s

A

dry mouth, water needed to swallow food, dental caries

29
Q

How to diagnose Sjogren’s?

A

Schimer tear test (tear flow over 5 minutes) or staining with rose Bengal to find epithelial abnormalities. lid biopsy for focal lymphocytic infiltrative of the minor salivary glands, Ab for Anti-Ro and anti-La

30
Q

Treatment for Sjogren’s is based on

A

Symptoms
Lachrymal substitues: hypromellose and lubricating ointment at night
Soft contact lenses
Artificial saliva and oral gels for xerostomia
Sugar free chewing gum, lozenges
Tx of oral candidiasis, vaginal dryness